Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Apicell Therapeutics
Developer of gene therapies for the treatment of immunological diseases
Sector
Subsector
Keywords
Location
Rocket Pharmaceuticals
Rocket Pharma is a clinical-stage biotech company developing gene therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
GeneVentiv Therapeutics
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on developing treatments for blood diseases and disorders.
Sector
Subsector
Location
total rounds
total raised
CommBio
Developer of gene therapies for the treatment of multiple disease conditions
Sector
Subsector
Location
M&A Details1
Transaction name
Acquired by
Alexion Pharmaceuticals
announced date
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 08.08.2011. Their latest round Venture - Series Unknown
Co-Investors
Investors8
Number of lead investors
Number of investors
Innova-Tech Consulting
Innova-Tech Consulting provides independent specialist audio visual and technology consulting services.
Sector
Subsector
Keywords
count Of Investments
count Of Exists
T2C2 Capital
T2C2 identifies and commercializes business opportunities in universities, research centers, and industry.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Jonathan Silverstein
Jonathan Silverstein, JD, joined OrbiMed Advisors, LLC in 1998 to focus on private equity and structured transactions in small capitalization public biotechnology and medical device companies. Mr. Silverstein was a Director of Life Sciences in the Investment Banking Department at the Sumitomo Bank and an Associate at Hambro Resource Development. Mr. Silverstein has a JD and an MBA from the University of San Diego, and a BA in Economics from Denison University. Currently, Mr. Silverstein is the Chairman of Enobia Pharma, Inc., Cerapedics, Inc., and Gelesis, and he is a Director at superDimension, Ltd., Glaukos Corporation and Nxstage Medical, Inc. He has been a Director or observer in more than a dozen other companies, including: LifeCell Corporation, Given Imaging, Ltd., Cerexa, Inc. (sold to Forest Laboratories, Inc.), Peninsula Pharmaceuticals, Inc. (sold to Johnson & Johnson, Inc.), Predix Pharmaceuticals, Inc.(sold to Epix Pharmaceuticals, Inc.), Avanir Pharmaceuticals, Inc., Orthovita, Inc., Auxillium Pharmaceuticals, Inc., Bioenvision (sold to Genzyme Corporation), Adiana, Inc. (sold to Cytyc Corporation) and Adolor Corporation.
current job
People
Employee Profiles15
Stephen Squinto
Executive Vice President, Chief Global Operations Officer.
Leonard Bell
Vice-President, Global Nephrology Franchise. ,Board of Director
David Hallal
Executive Vice President and Chief Commercial Officer
Clare Carmichael
Senior Vice President, Chief Human Resources Officer
Henric Bjarke
Vice President, Global Metabolic Diseases Franchise.